Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference call and ...

Citi analysts have taken action on two U.S. MedTech names, upgrading Haemonetics (NYSE:HAE) to Buy from Neutral, while downgrading Tandem Diabetes Care (NASDAQ:TNDM) to Sell/High Risk from ...